Zobrazeno 1 - 10
of 758
pro vyhledávání: '"Ose, L"'
Autor:
Wilemon, KA, Patel, J, Aguilar-Salinas, C, Ahmed, CD, Alkhnifsawi, M, Almahmeed, W, Alonso, R, Al-Rasadi, K, Badimon, L, Bernal, LM, Bogsrud, MP, Braun, LT, Brunham, L, Catapano, AL, Cillikova, K, Corral, P, Cuevas, R, Defesche, JC, Descamps, OS, de Ferranti, S, Eisele, JL, Elikir, G, Folco, E, Freiberger, T, Fuggetta, F, Gaspar, IM, Gesztes, AG, Groselj, U, Hamilton-Craig, I, Hanauer-Mader, G, Harada-Shiba, M, Hastings, G, Hovingh, GK, Izar, MC, Jamison, A, Karlsson, GN, Kayikcioglu, M, Koob, S, Koseki, M, Lane, S, Lima-Martinez, MM, Lopez, G, Martinez, TL, Marais, D, Marion, L, Mata, P, Maurina, I, Maxwell, D, Mehta, R, Mensah, GA, Miserez, AR, Neely, D, Nicholls, SJ, Nohara, A, Nordestgaard, BG, Ose, L, Pallidis, A, Pang, J, Payne, J, Peterson, AL, Popescu, MP, Puri, R, Ray, KK, Reda, A, Sampietro, T, Santos, RD, Schalkers, I, Schreier, L, Shapiro, MD, Sijbrands, E, Soffer, D, Stefanutti, C, Stoll, M, Sy, RG, Tamayo, ML, Tilney, MK, Tokgozoglu, L, Tomlinson, B, Vallejo-Vaz, AJ, Vazquez-Cardenas, A, de Luca, PV, Wald, DS, Watts, GF, Wenger, NK, Wolf, M, Wood, D, Zegerius, A, Gaziano, TA, Gidding, SS, Global Familial
Publikováno v:
JAMA Cardiology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
ImportanceFamilial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to premature morbidity and mortality due to atherosclerotic cardiovascular disease. Familial hypercholesterolemia affects 1 in 200 to 250 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::02f2867a3320f79afe99cde908232413
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2046
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2046
Autor:
Wilemon, KA, Patel, J, Aguilar-Salinas, C, Ahmed, CD, Alkhnifsawi, M, Almahmeed, W, Alonso, R, Al-Rasadi, K, Badimon, L, Bernal, LM, Bogsrud, MP, Braun, LT, Brunham, L, Catapano, AL, Cillíková, K, Corral, P, Cuevas, R, Defesche, JC, Descamps, OS, De Ferranti, S, Eiselé, J-L, Elikir, G, Folco, E, Freiberger, T, Fuggetta, F, Gaspar, IM, Gesztes, ÁG, Grošelj, U, Hamilton-Craig, I, Hanauer-Mader, G, Harada-Shiba, M, Hastings, G, Hovingh, GK, Izar, MC, Jamison, A, Karlsson, GN, Kayikçioglu, M, Koob, S, Koseki, M, Lane, S, Lima-Martinez, MM, López, G, Martinez, TL, Marais, D, Marion, L, Mata, P, Maurina, I, Maxwell, D, Mehta, R, Mensah, GA, Miserez, AR, Neely, D, Nicholls, SJ, Nohara, A, Nordestgaard, BG, Ose, L, Pallidis, A, Pang, J, Payne, J, Peterson, AL, Popescu, MP, Puri, R, Ray, KK, Reda, A, Sampietro, T, Santos, RD, Schalkers, I, Schreier, L, Shapiro, MD, Sijbrands, E, Soffer, D, Stefanutti, C, Stoll, M, Sy, RG, Tamayo, ML, Tilney, MK, Tokgözoglu, L, Tomlinson, B, Vallejo-Vaz, AJ, Vazquez-Cárdenas, A, De Luca, PV, Wald, DS, Watts, GF, Wenger, NK, Wolf, M, Wood, D, Zegerius, A, Gaziano, TA, Gidding, SS
Importance Familial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to premature morbidity and mortality due to atherosclerotic cardiovascular disease. Familial hypercholesterolemia affects 1 in 200 to 250
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::4e6b2e513615db903a218c6cf941805c
http://hdl.handle.net/10044/1/78721
http://hdl.handle.net/10044/1/78721
Autor:
Wiegman, A., Gidding, S., Watts, G., Chapman, M., Ginsberg, H., Cuchel, M., Ose, L., Averna, M., Boileau, C., Borén, J., Bruckert, E., Catapano, A., Defesche, J., Descamps, O., Hegele, R., Hovingh, G., Humphries, S., Kovanen, P., Kuivenhoven, J., Masana, L., Nordestgaard, B., Pajukanta, P., Parhofer, K., Raal, F., Ray, K., Santos, R., Stalenhoef, A., Steinhagen Thiessen, E., Stroes, E., Taskinen, M., Tybjealigrg Hansen, A., Wiklund, O.
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
European Heart Journal, 36, 36, pp. 2425-37
European Heart Journal, 36, 2425-37
European Heart Journal
Universidade de São Paulo (USP)
instacron:USP
European Heart Journal, 36, 36, pp. 2425-37
European Heart Journal, 36, 2425-37
European Heart Journal
Contains fulltext : 155263.pdf (Publisher’s version ) (Open Access) Familial hypercholesterolaemia (FH) is a common genetic cause of premature coronary heart disease (CHD). Globally, one baby is born with FH every minute. If diagnosed and treated e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33ccac215d3c0174bc67cc8258638a7e
http://eurheartj.oxfordjournals.org/
http://eurheartj.oxfordjournals.org/
Publikováno v:
Journal of International Medical Research. 27:115-129
This study examined the action of cerivastatin, a new statin, in subjects with primary hypercholesterolaemia. The effects of two oral doses of cerivastatin (400 micrograms/day or 300 micrograms/day) were compared with placebo in 349 patients using a
Autor:
Arnesen, K., Randsborg, K., Mork, I., Thorwall, M., Ose, L., Svilaas, A., Langslet, G., Wium, C., Retterstøl, K.
Publikováno v:
In Atherosclerosis August 2018 275:e182-e182
Autor:
Mundal, L., Igland, J., Veierød, M.B., Holven, K.B., Ose, L., Selmer, R., Wisløff, T., Kristiansen, I.S., Tell, G.S., Leren, T.P., Retterstøl, K.
Publikováno v:
In Atherosclerosis August 2018 275:e175-e175
Autor:
Arnesen, K., Randsborg, K., Mork, I., Thorwall, M., Ose, L., Svilaas, A., Langslet, G., Retterstøl, K.
Publikováno v:
In Atherosclerosis August 2018 275:e98-e98
Autor:
Ose, L., Davidson, M. H., Stein, E. A., Kastelein, J. J., Scott, R. S., Hunninghake, D. B., Campodonico, S., Insull, W., Escobar, I. D., Schrott, H. G., Stepanavage, M. E., Wu, M., Tate, A. C., Melino, M. R., Mercuri, M., Mitchel, Y. B.
Publikováno v:
Clinical cardiology, 23(1), 39-46. Wiley-Blackwell
Elevated levels of low-density lipoprotein (LDL) cholesterol promote the development of atherosclerosis and coronary heart disease. Simvastatin 80 mg/day will be more effective than simvastatin 40 mg/day at reducing LDL cholesterol and will be well t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::52f1ba6e7078d4102d4a2b4ef552d426
https://pure.amc.nl/en/publications/lipidaltering-efficacy-and-safety-of-simvastatin-80-mgday-longterm-experience-in-a-large-group-of-patients-with-hypercholesterolemia-world-wide-expanded-dose-simvastatin-study-group(29762bb7-864b-4f4b-a381-786c43262139).html
https://pure.amc.nl/en/publications/lipidaltering-efficacy-and-safety-of-simvastatin-80-mgday-longterm-experience-in-a-large-group-of-patients-with-hypercholesterolemia-world-wide-expanded-dose-simvastatin-study-group(29762bb7-864b-4f4b-a381-786c43262139).html
Autor:
Davidson, M. H., Stein, E. A., Hunninghake, D. B., Ose, L., Dujovne, C. A., Insull Jr, W., Bertolami, M., Weiss, S. R., Kastelein, J. J. P., Russell Scott, Campodónico, S., Escobar, I. D., Schrott, H. G., Bays, H., Stepanavage, M. E., Wu, M., Tate, A. C., Melino, M. R., Kush, D., Mercuri, M., Mitchel, Y. B.
Publikováno v:
Nutrition, metabolism, and cardiovascular diseases, 10(5), 253-262. Elsevier
Scopus-Elsevier
Scopus-Elsevier
Clinical data suggesting that larger decreases in low density lipoprotein cholesterol (LDL-C) result in greater reductions in coronary heart disease events have led to the establishment of aggressive LDL-C targets for the treatment of hypercholestero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d861fcbda411b771be408f450205a93a
https://pure.amc.nl/en/publications/lipidaltering-efficacy-and-safety-of-simvastatin-80-mgday-worldwide-longterm-experience-in-patients-with-hypercholesterolemia(ba4309e0-26c3-43dc-9a1d-1b55db5026e0).html
https://pure.amc.nl/en/publications/lipidaltering-efficacy-and-safety-of-simvastatin-80-mgday-worldwide-longterm-experience-in-patients-with-hypercholesterolemia(ba4309e0-26c3-43dc-9a1d-1b55db5026e0).html
Publikováno v:
In Atherosclerosis September 2016 252:e38-e38